跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Interferon tau
首页
药物
Interferon tau
Investigational
Biotech
Interferon tau
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Orally-administered interferon-tau compositions and methods
US 6942854 B2
申请人: UNIV FLORIDA
优先权: 2001
US
4 件公开
Low-toxicity, long-circulating human interferon-alpha PEGylated mutants
US 7662370 B2
申请人: PEPGEN CORP
优先权: 2005
CN
US
3 件公开
Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAU
US 6982081 B2
申请人: PEPGEN CORP
优先权: 2001
US
3 件公开
Method of treatment using interferon-tau
US 7105154 B2
申请人: PEPGEN CORP
优先权: 2003
US
3 件公开
US 2006134750 A1
申请人: PEPGEN CORP
优先权: 2005
CN
US
2 件公开
US 7083782 B2
申请人: PEPGEN CORP
优先权: 2004
US
2 件公开
US 2004247565 A1
申请人: LIU CHIH-PING
优先权: 2004
US
US 2005118137 A1
申请人: LIU CHIH-PING
优先权: 2004
US
US 2005118138 A1
申请人: LIU CHIH-PING
优先权: 2004
US
US 2005226845 A1
申请人: LIU CHIH-PING
优先权: 2005
US
US 2006078942 A1
申请人: PEPGEN CORP
优先权: 2005
US
INTERFERON TAU FC-FUSION PROTEINS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS
US 2024018207 A1
申请人: SOUTHLAKE PHARMACEUTICALS INC
优先权: 2020
CN
US
2 件公开
Hybrid interferon/interferon tau proteins, compositions and methods of use
US 7232563 B2
申请人: PEPGEN CORP
优先权: 2002
US
2 件公开
Materials and methods for inhibition of IgE production
US 2006257364 A1
申请人: JOHNSON HOWARD M
优先权: 2003
US
2 件公开
Method of treating IL-10 deficiency
US 7431920 B2
申请人: PEPGEN CORP
优先权: 2005
US
2 件公开
Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
US 7695710 B2
申请人: PEPGEN CORP
优先权: 2007
US
2 件公开
Fusion protein consisting of sheep interleukin 2, sheep interferon gamma and sheep interferon tau and preparation method thereof
CN 108840953 A
申请人: WUHU YINGTEFEIER BIO PRODUCT INDUSTRY RES INSTITUTE CO LTD
优先权: 2017
CN
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈